drugset / Trial / NCT02218190

Alvimopan and Ileus in PSF

NCT02218190

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to determine with Alvimopan reduces the incidence of post operative ileus in patients who undergo posterior spinal fusion.

Timeline

Start
2014-08
Primary completion
2016-01
Completion
2019-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alvimopan Small molecule 2 mg Oral

Indications